JP2005519123A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519123A5
JP2005519123A5 JP2003573134A JP2003573134A JP2005519123A5 JP 2005519123 A5 JP2005519123 A5 JP 2005519123A5 JP 2003573134 A JP2003573134 A JP 2003573134A JP 2003573134 A JP2003573134 A JP 2003573134A JP 2005519123 A5 JP2005519123 A5 JP 2005519123A5
Authority
JP
Japan
Prior art keywords
medicament according
protein
antigen
vegetative cell
bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003573134A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519123A (ja
Filing date
Publication date
Priority claimed from GBGB0205376.7A external-priority patent/GB0205376D0/en
Application filed filed Critical
Publication of JP2005519123A publication Critical patent/JP2005519123A/ja
Publication of JP2005519123A5 publication Critical patent/JP2005519123A5/ja
Withdrawn legal-status Critical Current

Links

JP2003573134A 2002-03-07 2003-03-07 組換え胞子 Withdrawn JP2005519123A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205376.7A GB0205376D0 (en) 2002-03-07 2002-03-07 Spore germination
PCT/GB2003/000966 WO2003074681A1 (en) 2002-03-07 2003-03-07 Recombinant spores

Publications (2)

Publication Number Publication Date
JP2005519123A JP2005519123A (ja) 2005-06-30
JP2005519123A5 true JP2005519123A5 (cg-RX-API-DMAC7.html) 2006-04-27

Family

ID=9932499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003573134A Withdrawn JP2005519123A (ja) 2002-03-07 2003-03-07 組換え胞子

Country Status (9)

Country Link
US (1) US20050287168A1 (cg-RX-API-DMAC7.html)
EP (1) EP1495110A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005519123A (cg-RX-API-DMAC7.html)
KR (1) KR20040099293A (cg-RX-API-DMAC7.html)
CN (1) CN1639322A (cg-RX-API-DMAC7.html)
AU (1) AU2003214391A1 (cg-RX-API-DMAC7.html)
GB (1) GB0205376D0 (cg-RX-API-DMAC7.html)
RU (1) RU2004129739A (cg-RX-API-DMAC7.html)
WO (1) WO2003074681A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503509D0 (en) * 2005-02-19 2005-03-30 New Royal Holloway & Bedford An improved delivery agent
JP2008231063A (ja) * 2007-03-22 2008-10-02 Takano Foods Kk 納豆菌ワクチン
WO2010006326A2 (en) * 2008-07-11 2010-01-14 Tufts University Methods and compositions for spore-based vaccines
US9610333B2 (en) * 2008-07-11 2017-04-04 Tufts University Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines
WO2011111783A1 (ja) * 2010-03-12 2011-09-15 カルピス株式会社 大腸におけるビフィズス菌の増加及び減少抑制剤
US20240254434A1 (en) 2019-12-18 2024-08-01 Exomnis Biotech Bv Genetically modified clostridium strains and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668255A (en) * 1984-06-07 1997-09-16 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE69002817T2 (de) * 1989-11-28 1993-12-09 Wellcome Found Vakzine.
US6280721B1 (en) * 1989-12-18 2001-08-28 Valent Biosciences, Inc. Production of Bacillus thuringiensis integrants
SK55593A3 (en) * 1991-03-05 1993-10-06 Wellcome Found Expresion of recombinant proteins in attenuated bacteria
US5340577A (en) * 1992-07-29 1994-08-23 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
GB9401787D0 (en) * 1994-01-31 1994-03-23 Medeva Holdings Bv Vaccine compositions
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
US5800821A (en) * 1995-03-10 1998-09-01 New England Medical Center Hospitals, Inc. Bacterial spores as a heat stable vaccine delivery system
US5707353A (en) * 1995-12-21 1998-01-13 Abbott Laboratories Oral administration of beneficial agents
US6372225B1 (en) * 1996-03-23 2002-04-16 The Research Foundation Of Microbial Diseases Of Osaka University Tetanus toxin functional fragment antigen and tetanus vaccine
US5707127A (en) * 1996-06-26 1998-01-13 Kain; Meira Three-dimensional image viewing apparatus
DE29724815U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
US7923216B2 (en) * 1997-08-14 2011-04-12 Institut Pasteur In vivo modulation of neuronal transport
US7923015B2 (en) * 1997-08-14 2011-04-12 Institut Pasteur Methods for direct visualization of active synapses
US6730499B1 (en) * 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
US6090417A (en) * 1999-03-24 2000-07-18 Kraft Foods, Inc. Nutritional fortification of natural cheese and method of making
US7186560B2 (en) * 1999-09-21 2007-03-06 Rutgers, The State University Of New Jersey High level expression of immunogenic proteins in the plastids of higher plants
GB0009470D0 (en) * 2000-04-17 2000-06-07 Univ Southampton Materials and methods relating to immune responses to fusion proteins
WO2001094599A1 (en) * 2000-06-07 2001-12-13 Smittskyddsinstitutet Gene expression cassette and its use
US6881558B1 (en) * 2000-06-26 2005-04-19 The Trustees Of The University Of Pennsylvania Expression system for cloning toxic genes
US20020150594A1 (en) * 2000-06-26 2002-10-17 Maxygen, Inc. Methods and compositions for developing spore display systems for medicinal and industrial applications
WO2002000232A2 (en) * 2000-06-26 2002-01-03 Maxygen, Inc. Methods and compositions for developing spore display systems for medicinal and industrial applications
KR20020045400A (ko) * 2000-12-08 2002-06-19 반재구 포자 표면발현 방법
GB0130789D0 (en) * 2001-12-21 2002-02-06 King S College London Application of spores

Similar Documents

Publication Publication Date Title
Subramanian et al. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen
ATE513560T1 (de) Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird
Boyaka et al. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen
Lamont et al. Subgingival colonization by Porphyromonas gingivalis
WO2002000232A3 (en) Methods and compositions for developing spore display systems for medicinal and industrial applications
Ishihara Virulence factors of Treponema denticola.
IL264925A (en) Isolated or recombinant proteins that induce an immune response against S. PYOGENES, preparations containing them and their uses
HRP20041152B1 (hr) Farmaceutske formulacije
NO20053142L (no) Allergen doseringsform.
NO20072906L (no) Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
Converso et al. Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice
ATE255905T1 (de) Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält
WO2002012294A3 (en) Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
EP2502998A3 (en) Recombinant toxin A/ToxinB vaccine against clostridium difficile
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
NO20030231L (no) Proteinkompleks som fungerer som en vehikkel for oralt administrerbare medikamenter
AU2001269927A1 (en) Thrombomodulin analogs for pharmaceutical use
ATE404214T1 (de) Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält
NO20070775L (no) Baerer for medikamenter for oppnaelse av oral biotilgjengelighet
RU2004129738A (ru) Бактериальные споры
BRPI0413509A (pt) uso de antibióticos de quinolona
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
DE69902271D1 (de) Einnehmbare produkte
DK0983361T3 (da) Bakterielle pheromoner og anvendelser deraf